Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New devices in liver replacement therapy].

Kinan Rifai1, Matthias J Bahr, Andrea Schneider

  • 1Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule, Hannover.

Medizinische Klinik (Munich, Germany : 1983)
|December 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.

Journal of hepatology·2026
Same author

In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.

Journal of hepatology·2026
Same author

Treatment of liver failure utilizing multi-cell lineage liver microtissue.

JHEP reports : innovation in hepatology·2026
Same author

Use of Machine Learning to Identify Markers of Risk for Fragile X-Associated Tremor/Ataxia Syndrome: A Preliminary Analysis.

Annals of neurology·2026
Same author

Comprehensive, multidisciplinary care for fragile X-associated tremor/ataxia syndrome.

Frontiers in neurology·2026
Same author

<i>De novo</i> and quiescent cGVHD are distinguishable in a prognostic biomarker panel.

Frontiers in immunology·2026

Liver failure has high mortality despite transplantation. Liver replacement therapies, including artificial devices and cell transplantation, are being tested but require more survival data and should be used in specialized clinical studies.

Area of Science:

  • Hepatology
  • Regenerative Medicine
  • Transplantation Biology

Background:

  • Liver failure presents a significant mortality risk, even with liver transplantation.
  • Existing liver replacement therapies aim to manage acute liver decompensation.
  • Artificial devices, bioartificial systems, and hepatocyte transplantation are under clinical investigation.

Purpose of the Study:

  • To evaluate the current status and clinical applicability of liver replacement therapies.
  • To highlight the need for more robust data on patient survival.
  • To provide guidance on the appropriate use of these emerging therapies.

Main Methods:

  • Review of existing clinical data and ongoing trials for liver replacement therapies.
  • Analysis of survival outcomes associated with artificial and bioartificial liver support systems.

Related Experiment Videos

  • Assessment of hepatocyte transplantation efficacy in liver failure patients.

    • Main Results:

    • Limited controlled data exist regarding the efficacy of current liver replacement strategies.
    • Patient survival data for these advanced therapies remain scarce.
    • Varied approaches including artificial organs and cell-based therapies are in clinical trials.

    Conclusions:

    • Liver replacement therapies show promise but require further validation.
    • Controlled clinical studies are essential to determine patient survival benefits.
    • Current use of liver replacement therapies should be restricted to specialized centers within clinical trials.